Diabetic Nephropathy in T2DM: Blood Pressure and Cholesterol Targets Nemanja Stojanović Consultant Endocrinologist Queens Hospital, Romford.
Disease and Gene Associations Elizabeth R. Hauser Duke University Center for Human Genetics North Carolina Genomics Symposium March 18, 2005.
Malaysian Society of Nephrology Ministry of Health Malaysia Hypertension In Chronic Kidney Disease.
Diabetes Mellitus Jane DisaSmith, D.O. Dec. 13, 2005 Slides by Billie Hall, D.O.
DIABETES/BILIARY MCC NURSING Diana Blum MSN. DEFINITION Disorder of carbohydrate, protein, and fat metabolism resulting from an imbalance between insulin.
Dr Hossein Soleymani Assistant Prof of Rheumatology SSMU, Jan 2015, YAZD, IRAN.
D iabetes I n C anada Evaluation (The DICE Study): Impact on Family Practice Stewart B. Harris MD MPH FCFP FACPM Associate Professor Centre for Studies.
CUTANEOUS MANIFESTATIONS OF HEPATITIS B and C VIRUS INFECTIONS Marie-Sylvie DOUTRE Bordeaux (France)
Diabetes, Obesity & Metabolism Research in the Early 21 st Century* (*from the NIH Point of View) December, 2004 Maren R. Laughlin, Ph.D. Senior Advisor.
Co-organised by: Sponsored by: Supported by: Exercise Prescription Certificate Course (2014/15) Session 4: Exercise Recommendations for Persons with Special.
1 COZAAR™ (losartan) in Type 2 Diabetes and Nephropathy Michael C. Elia, PhD Director, Regulatory Affairs Merck Research Laboratories.
